MedElevator
Войти в исследования Critical care medicine · 2026
Prevalence, Risk Factors, and Mortality of Veno-Venous Extracorporeal Membrane Oxygenation Escalation in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study From the Chinese Society of Extracorporeal Life Support Registry.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ma Sicong, Pan Yihan, He Jie, Xie Haixiu, Cen Zhongran, Liu Xingxing, Cai Jing, Huang Bo, Wang Hua, Du Zhongtao, Hou Xiaotong, Liu Zhanguo
Аннотация
OBJECTIVES: Patients with acute respiratory distress syndrome (ARDS) undergoing venovenous extracorporeal membrane oxygenation (ECMO) may experience severe cardiogenic shock, necessitating ECMO mode "escalation" for cardiopulmonary co-support. There is a paucity of data regarding the prevalence, risk factors, and mortality of venovenous ECMO escalation. We aimed to conduct a large study to address this issue.
DESIGN: A multicenter cohort study.
SETTING: The analysis was conducted based on data from the Chinese Society of Extracorporeal Life Support registry, a nationwide voluntary platform capturing clinical information of patients receiving ECMO support. Data were collected from 112 centers across China between January 2017 and December 2023.
PATIENTS: Eligible participants included adult patients with ARDS receiving venovenous ECMO, excluding pregnant patients and those with missing data on escalation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was in-hospital mortality. Of the 3333 patients on venovenous ECMO, 157 (4.7%) underwent escalation to venoarterial ECMO ( n = 41), veno-arterial-venous (VAV) ECMO ( n = 68), and veno-veno-arterial (VVA) ECMO ( n = 48). Several characteristics, including hospital's annual venovenous ECMO volume (hospitals > 15 cases per year vs. those < 6 cases per year; odds ratio [OR], 0.596; 95% CI, 0.382-0.930), were associated with the occurrence of escalation. The overall in-hospital mortality was 47.9%. Both escalation and lower hospital's venovenous ECMO volume were independently associated with an increased mortality. Compared with patients escalated to VVA ECMO, those escalated to venoarterial ECMO had a significantly higher survival rate (OR, 3.444; 95% CI, 1.046-11.342), whereas those escalated to VAV ECMO did not.
CONCLUSIONS: In this study, 4.7% of ARDS patients with venovenous ECMO underwent a mode escalation. Escalation was independently associated with higher in-hospital mortality, an association that may be partially confounded by low hospital's venovenous ECMO volume. Among the modes after escalation, venoarterial ECMO was associated with a significantly higher survival rate. These findings require validation by further prospective multicenter studies to guide decision-making for ARDS patients requiring ECMO support.
DESIGN: A multicenter cohort study.
SETTING: The analysis was conducted based on data from the Chinese Society of Extracorporeal Life Support registry, a nationwide voluntary platform capturing clinical information of patients receiving ECMO support. Data were collected from 112 centers across China between January 2017 and December 2023.
PATIENTS: Eligible participants included adult patients with ARDS receiving venovenous ECMO, excluding pregnant patients and those with missing data on escalation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was in-hospital mortality. Of the 3333 patients on venovenous ECMO, 157 (4.7%) underwent escalation to venoarterial ECMO ( n = 41), veno-arterial-venous (VAV) ECMO ( n = 68), and veno-veno-arterial (VVA) ECMO ( n = 48). Several characteristics, including hospital's annual venovenous ECMO volume (hospitals > 15 cases per year vs. those < 6 cases per year; odds ratio [OR], 0.596; 95% CI, 0.382-0.930), were associated with the occurrence of escalation. The overall in-hospital mortality was 47.9%. Both escalation and lower hospital's venovenous ECMO volume were independently associated with an increased mortality. Compared with patients escalated to VVA ECMO, those escalated to venoarterial ECMO had a significantly higher survival rate (OR, 3.444; 95% CI, 1.046-11.342), whereas those escalated to VAV ECMO did not.
CONCLUSIONS: In this study, 4.7% of ARDS patients with venovenous ECMO underwent a mode escalation. Escalation was independently associated with higher in-hospital mortality, an association that may be partially confounded by low hospital's venovenous ECMO volume. Among the modes after escalation, venoarterial ECMO was associated with a significantly higher survival rate. These findings require validation by further prospective multicenter studies to guide decision-making for ARDS patients requiring ECMO support.